Condition
Economic Burden
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Enrolling By Invitation1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06893731Enrolling By Invitation
Healthcare Utilization and Economic Burden of Cardiomyopathy in China
NCT06068309Not ApplicableCompleted
Efficacy of CareAide® App in Improving Adherence in Adults With Chronic Diseases
NCT02592265Completed
Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden
NCT06487130Recruiting
Virtual perI-/Menopause Registry of AusTrALia
NCT04482205CompletedPrimary
Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures
Showing all 5 trials